HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 69 filers reported holding HILLEVAX INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $260,891 | +37.0% | 15,688 | +32.3% | 0.00% | – |
Q4 2023 | $190,385 | +32.8% | 11,862 | +11.3% | 0.00% | – |
Q3 2023 | $143,310 | -25.4% | 10,655 | -4.6% | 0.00% | – |
Q2 2023 | $192,064 | +25.0% | 11,173 | +21.6% | 0.00% | – |
Q4 2022 | $153,699 | +15269.9% | 9,187 | +12839.4% | 0.00% | – |
Q3 2022 | $1,000 | – | 71 | +610.0% | 0.00% | – |
Q2 2022 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 9,781,472 | $161,687,732 | 11.71% |
Qiming U.S. Ventures Management, LLC | 558,923 | $9,238,997 | 11.18% |
Samsara BioCapital, LLC | 609,862 | $10,081,019 | 2.08% |
StepStone Group LP | 676,569 | $11,183,686 | 2.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,833,690 | $46,840,896 | 1.04% |
Carlyle Group Inc. | 1,838,486 | $30,096,016 | 0.90% |
BRAIDWELL LP | 1,620,216 | $26,782,170 | 0.88% |
RA Capital Management | 1,760,019 | $29,093,114 | 0.66% |
Perceptive Advisors | 406,024 | $6,711,577 | 0.20% |
BVF INC/IL | 248,579 | $4,109,011 | 0.15% |